Staff from the University of Malta’s TargetMI project hosted their partners Prof. Frits Rosendaal, Chair of the Department of Clinical Epidemiology, Dr Bart van Vlijmen from the Section of Thrombosis and Haemostasis of the Department of Internal Medicine, Prof. Astrid van Hylckama Vlieg from the Department of Clinical Epidemiology, and Ms Britte van der Vliet from Leiden University Medical Center (LUMC) in April 2024 for the first Consortium meeting.
The teams met in person and presented updates on the work being carried out. This led to some interesting discussions, and meetings with UM Director of the , , as well as from the .
TargetMI: A Multi-Omics Approach for Novel Drug Targets, Biomarkers and Risk Algorithms for Myocardial Infarction is a 5-year €4 million project funded by Horizon Europe’s European Innovation Council’s Pathfinder Programme. The project kicked off in October 2023 and is coordinated by from the , Faculty of Health Sciences and the CMMB, University of Malta (UM), and the team from LUMC is led by Prof. Frits Rosendaal. Members of the project, led by , also from the CMMB and the (UM), are also assisting with the project.
Cardiovascular disease is a major cause of death and morbidity worldwide, with highly complex causes that involve genetic, lifestyle, and environmental factors. The goal of TargetMI is to combat coronary heart disease by developing biomarkers & risk algorithms to identify people at risk and applying a data-driven high throughput multi-omic approach for the rapid discovery of novel drug targets.
More information is available .
Project ¸£ÀûÔÚÏßÃâ·Ñs can be followed .
